Managed by CCB International and co-operated by Beijing New Aerotropolis Fund Management Co., Ltd, Jianxing Medical Fund is part of a series of equity investment funds established by CCB International to develop the medical and health industry in China. The fund specifically targets high-quality projects in the growth stage of innovative drugs, high-end medical equipment, and intelligent medical treatment.